Dihomo-γ-linolenic acid
Dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system[1][2][3].
Product Specifications
CAS Number
1783-84-2
Product Name Alternative
DGLA; all-cis-8,11,14-Eicosatrienoic acid
UNSPSC
12352211
Hazard Statement
H227, H302
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/_8Z,11Z,14Z_-Icosa-8,11,14-trienoic_acid.html
Concentration
326.28 mM * 50 μL in Ethanol
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(O)=O
Molecular Formula
C20H34O2
Molecular Weight
306.48
Precautions
H227, H302
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Natural Products
Clinical Information
Launched
Isoform
Human Endogenous Metabolite
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
